InsidersTradesSigma
Track the 株式会社レオクラン stock price and the full insider trade history of the company, a listed equity based in Japan. Shares are quoted on the JP market, under the authority of EDINET (Japan FSA). Operating in the Health Care sector, 株式会社レオクラン has published 11 public disclosures. Market capitalisation: €5.7bn. The latest transaction was filed on 16 June 2026 (Holding update). Among the most active insiders: Hikari Tsushin K.K.. All data is free.
11
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
17Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,113 of 29,156 companies
31.2
score / 100
Value37
Quality26
FCF yld-2.8%
Earn yld2.6%
EV/EBITDA15.8x
ROE2.2%
Gross mgn13%
Net mgn0.7%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 16 June 2026
Declarations11 total
ShareXTKSEDINET:S100YA92
ShareXTKSEDINET:S100Y75K
ShareXTKSEDINET:S100Y5RP
ShareXTKSEDINET:S100XB6W
ShareXTKSEDINET:S100WQK7
15.2% of flowShareXTKSEDINET:S100WELU
15.7% of flowShareXTKSEDINET:S100TCF2
16.0% of flowShareXTKSEDINET:S100SBDK
31.9% of flowShareXTKSEDINET:S100QX5S
32.9% of flowShareXTKSEDINET:S100QTSC
35.2% of flowShareXTKSEDINET:S100PVXD
11 of 11 declarations
About 株式会社レオクラン
株式会社レオクラン is a Japanese company operating in the healthcare and pharmaceutical sector. It is listed on the XTKS market.